Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AstraZeneca PLC | Stockholm | Healthcare | Pharmaceuticals | SEK 2.27T | 31.3x | 3.21 | SEK 1,475.50 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.8% Upside | Upgrade to Pro+ | |
Swedish Orphan Biovitrum | Stockholm | Healthcare | Pharmaceuticals | SEK 110.66B | 31.6x | 2.34 | SEK 322.80 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.6% Upside | Upgrade to Pro+ | |
Camurus AB | Stockholm | Healthcare | Pharmaceuticals | SEK 34.29B | 125.4x | -2.92 | SEK 585 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.2% Upside | Upgrade to Pro+ | |
Bonesupport | Stockholm | Healthcare | Pharmaceuticals | SEK 26.30B | 288.8x | -4.97 | SEK 398.60 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.4% Upside | Upgrade to Pro+ | |
Vimian Group AB | Stockholm | Healthcare | Pharmaceuticals | SEK 20.82B | 62,552.2x | 71.37 | SEK 40.20 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.1% Upside | Upgrade to Pro+ | |
BioGaia B | Stockholm | Healthcare | Pharmaceuticals | SEK 11.30B | 33.6x | -1.46 | SEK 111.40 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34% Upside | Upgrade to Pro+ | |
Swedencare | Stockholm | Healthcare | Pharmaceuticals | SEK 7.63B | 123.1x | -4.25 | SEK 48.20 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.2% Upside | Upgrade to Pro+ | |
Probi AB | Stockholm | Healthcare | Pharmaceuticals | SEK 3.98B | 364.4x | -17.95 | SEK 349 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Flerie AB | Stockholm | Healthcare | Pharmaceuticals | SEK 3.71B | -448.5x | SEK 47.56 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.8% Upside | Upgrade to Pro+ | ||
Cinclus Pharma Holding AB | Stockholm | Healthcare | Pharmaceuticals | SEK 994.98M | -4x | SEK 22.20 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Infant Bacterial Therapeutics | Stockholm | Healthcare | Pharmaceuticals | SEK 746.32M | -5.1x | 1.73 | SEK 57.40 | 7.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Magle Chemoswed | Stockholm | Healthcare | Pharmaceuticals | SEK 640.39M | 21.9x | 0.35 | SEK 38 | 9.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37.9% Upside | Upgrade to Pro+ | |
Orexo AB | Stockholm | Healthcare | Pharmaceuticals | SEK 628M | -6x | -0.12 | SEK 18.20 | 4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.9% Upside | Upgrade to Pro+ | |
IRLAB Therapeutics | Stockholm | Healthcare | Pharmaceuticals | SEK 554.99M | -4.9x | -0.14 | SEK 10.70 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Moberg Pharma | Stockholm | Healthcare | Pharmaceuticals | SEK 479.07M | -18.5x | -0.4 | SEK 10.17 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.6% Downside | Upgrade to Pro+ | |
Dicot | Stockholm | Healthcare | Pharmaceuticals | SEK 431.35M | -3.2x | -0.24 | SEK 0.27 | 10.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Isofol Medical | Stockholm | Healthcare | Pharmaceuticals | SEK 387.64M | -9.9x | -0.41 | SEK 2.47 | 11.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Enzymatica publ AB | Stockholm | Healthcare | Pharmaceuticals | SEK 349.55M | -5.2x | -0.55 | SEK 1.64 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cessatech AS | Spotlight | Healthcare | Pharmaceuticals | SEK 316.22M | -12.4x | -0.32 | SEK 18.17 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lipum | Stockholm | Healthcare | Pharmaceuticals | SEK 254.55M | -4.9x | -0.14 | SEK 13 | 8.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | |
Corline Biomedical AB | Stockholm | Healthcare | Pharmaceuticals | SEK 204.16M | -21x | 0.02 | SEK 9.56 | 8.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Enorama Pharma | Stockholm | Healthcare | Pharmaceuticals | SEK 199.56M | -4.4x | -0.09 | SEK 3.30 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lipidor | Stockholm | Healthcare | Pharmaceuticals | SEK 173.25M | -0.4x | -0.19 | SEK 0.24 | 13.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vivesto AB | Stockholm | Healthcare | Pharmaceuticals | SEK 150.65M | -1.6x | -0.02 | SEK 0.28 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.6% Upside | Upgrade to Pro+ | |
Pila Pharma AB | Stockholm | Healthcare | Pharmaceuticals | SEK 101.72M | -15.1x | -0.21 | SEK 3.99 | 6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Elicera Therapeutics AB | Stockholm | Healthcare | Pharmaceuticals | SEK 58.61M | -2.8x | -0.22 | SEK 1.74 | 4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.7% Upside | Upgrade to Pro+ | |
ExpreS2ion Biotech | Stockholm | Healthcare | Pharmaceuticals | SEK 49.15M | -1x | -0.02 | SEK 24.40 | 18.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncozenge AB | Stockholm | Healthcare | Pharmaceuticals | SEK 43.92M | -5.5x | -0.11 | SEK 3.54 | -5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Odi Pharma | Spotlight | Healthcare | Pharmaceuticals | SEK 33.79M | 145.6x | 0.93 | SEK 2.50 | 12.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lipigon Pharmaceuticals AB | Stockholm | Healthcare | Pharmaceuticals | SEK 17.12M | -0.9x | -0.08 | SEK 0.12 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |